This topic contains a solution. Click here to go to the answer

Author Question: What is the major adverse risk when administering an enteral supplemental feeding to a patient ... (Read 59 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
What is the major adverse risk when administering an enteral supplemental feeding to a patient through a feeding tube?
 
  a. Aspiration of tube feeding contents.
  b. Abdominal pain when given too fast.
  c. Toxicity from too many vitamins and minerals.
  d. Peritonitis if the bowel ruptures.

Question 2

A patient is receiving supplemental enteral
 
  feedings with Osmolite, 1 can three times a day between meals. For which main side effect should you monitor?
  a. Constipation
  b. Nausea
  c. Vomiting
  d. Diarrhea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Danny Ewald

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

ANS: A

Answer to Question 2

ANS: D




nummyann

  • Member
  • Posts: 576
Reply 2 on: Jul 23, 2018
Excellent


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

After a vasectomy, it takes about 12 ejaculations to clear out sperm that were already beyond the blocked area.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library